DK0575974T3 - - Google Patents

Info

Publication number
DK0575974T3
DK0575974T3 DK93110006.9T DK93110006T DK0575974T3 DK 0575974 T3 DK0575974 T3 DK 0575974T3 DK 93110006 T DK93110006 T DK 93110006T DK 0575974 T3 DK0575974 T3 DK 0575974T3
Authority
DK
Denmark
Prior art keywords
rickets
antirachitic
dihydroxycholecalciferol
intrinsic
agents
Prior art date
Application number
DK93110006.9T
Other languages
English (en)
Inventor
Yoshiki Seino
Hiroyuki Tanaka
Yumiko Nagai
Original Assignee
Kureha Chemical Ind Co Ltd
Yoshiki Seino
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Chemical Ind Co Ltd, Yoshiki Seino filed Critical Kureha Chemical Ind Co Ltd
Application granted granted Critical
Publication of DK0575974T3 publication Critical patent/DK0575974T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK93110006.9T 1992-06-23 1993-06-23 DK0575974T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4188672A JP2876547B2 (ja) 1992-06-23 1992-06-23 抗クル病剤

Publications (1)

Publication Number Publication Date
DK0575974T3 true DK0575974T3 (da) 1997-02-24

Family

ID=16227833

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93110006.9T DK0575974T3 (da) 1992-06-23 1993-06-23

Country Status (7)

Country Link
US (1) US5508274A (da)
EP (1) EP0575974B1 (da)
JP (1) JP2876547B2 (da)
KR (1) KR940005277A (da)
AT (1) ATE147267T1 (da)
DE (1) DE69307197T2 (da)
DK (1) DK0575974T3 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4535174B2 (ja) 2008-07-11 2010-09-01 トヨタ自動車株式会社 車両の制御装置および制御方法
CN107019795A (zh) * 2009-01-27 2017-08-08 博格有限责任公司 用于减轻与化疗有关的副作用的维生素d3化合物
MX366076B (es) 2009-08-14 2019-06-27 Berg Llc Vitamina d3 y analogos de la misma para tratar alopecia.
NZ714801A (en) 2013-05-29 2021-07-30 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin d

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3715374A (en) * 1972-05-05 1973-02-06 Wisconsin Alumni Res Found 24,25-dihydroxycholecalciferol
US4021423A (en) * 1976-03-08 1977-05-03 Hoffmann-La Roche Inc. Syntheses of 24R,25- and 24S,25-dihydroxycholecalciferol
US4028349A (en) * 1976-03-08 1977-06-07 Hoffmann-La Roche Inc. Syntheses of 24R,25- and 24S,25-dihydroxycholesterol 24,25-ketals and alkanoyl derivatives thereof
US4224231A (en) * 1979-09-04 1980-09-23 Wisconsin Alumni Research Foundation Derivatives of 25-hydroxycholecalciferol
IL74617A (en) * 1985-03-15 1988-11-15 Yeda Res & Dev Compositions comprising a vitamin d derivative and method for the local treatment of bone fractures in animals
IL77668A (en) * 1986-01-21 1989-03-31 Teva Pharma Production of cholecalciferol derivatives and novel intermediates used therefor
US5001118A (en) * 1986-12-29 1991-03-19 Kureha Kagaku Kogyo Kabushiki Kaisha Method for preventing senescence and increasing bone mass
US4997824A (en) * 1987-07-22 1991-03-05 Teva Pharmaceutical Industries Ltd. Combination of cholecalciferol derivatives for the treatment of renal bone disease
US4897388A (en) * 1988-12-20 1990-01-30 Geriatric Research Institute, Inc. Method of treating Alzheimer's disease

Also Published As

Publication number Publication date
EP0575974A1 (en) 1993-12-29
ATE147267T1 (de) 1997-01-15
DE69307197T2 (de) 1997-04-24
JPH069406A (ja) 1994-01-18
JP2876547B2 (ja) 1999-03-31
KR940005277A (ko) 1994-03-21
US5508274A (en) 1996-04-16
EP0575974B1 (en) 1997-01-08
DE69307197D1 (de) 1997-02-20

Similar Documents

Publication Publication Date Title
HK1008180A1 (en) Use of vitamin d 2 or vitamin d 4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism
CA2125888A1 (en) Pharmaceutically active antioxidant containing composition and the method of its use to prevent and treat restenosis following angioplasty
HRP920667B1 (en) Application of fultripine active substance for preventing muscle deformation
IL106562A0 (en) Pharmaceutical and/or cosmetic compositions and the use thereof
TW234691B (da)
EP0713699A3 (da)
IL91949A (en) Dispersible formulation containing the free acid form of diclofenac
GB8920806D0 (en) The treatment of bone disorders
HU9301578D0 (en) Fungicidal preparatives containing 1-aryl-3-(3,4-dihydro-4-oxo-3-quinazolinyl)-urea as active substance
FR2687913B1 (da)
AU621763B2 (en) Stable tretinoin emulsified cream formulations
DK0575974T3 (da)
IL105475A0 (en) Pharmaceutical compositions containing 1alpha,24(r)-dihydroxy-22(e)-dehydro-vitamin d3 for treating osteoporosis
ES2103220B1 (es) Desodorantes de los efluentes de papelera a base de ester de acido undecilenico.
IL89392A (en) Compositions for the treatment of osteoporosis in humans comprising 24, 25-dihydroxy-vitamin d3
IL78269A (en) Dermatological therapeutical compositions containing imidazolidinylurea derivative
CA2112501A1 (fr) Composition therapeutique nouvelle remediant aux desordres survenant dans la sphere orl
IE831131L (en) Use of a cholecalciferol derivative
EP0987022A4 (en) PREVENTIVE AND HEALING MEDICINES FOR ULCERATIVE KOLITIS AND / OR MORBUS CROHN
IT1254938B (it) Derivati otticamente attivi della n-imminoalchil-n'-((2-idrossi- 2-fenil-2-cicloesil)-etil)-piperazina